BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25846868)

  • 1. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.
    Bhatia V; Falzon M
    Cancer Lett; 2015 Jul; 362(2):199-207. PubMed ID: 25846868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.
    Larriba MJ; Bonilla F; Muñoz A
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):106-9. PubMed ID: 20138990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
    Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
    Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
    Larriba MJ; Martín-Villar E; García JM; Pereira F; Peña C; de Herreros AG; Bonilla F; Muñoz A
    Carcinogenesis; 2009 Aug; 30(8):1459-68. PubMed ID: 19502595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor and retinoid X receptor α status and vitamin D insufficiency in models of murine colitis.
    Knackstedt RW; Moseley VR; Sun S; Wargovich MJ
    Cancer Prev Res (Phila); 2013 Jun; 6(6):585-93. PubMed ID: 23585425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.
    Velmurugan B; Gangar SC; Kaur M; Tyagi A; Deep G; Agarwal R
    Pharm Res; 2010 Oct; 27(10):2085-97. PubMed ID: 20628792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
    Kumar S; Raina K; Agarwal C; Agarwal R
    Oncotarget; 2014 Jul; 5(13):4972-89. PubMed ID: 24970802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
    Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling.
    Raina K; Agarwal C; Agarwal R
    Mol Carcinog; 2013 Mar; 52(3):195-206. PubMed ID: 22086675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
    Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
    PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
    DeSmet ML; Fleet JC
    J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3).
    Wang X; Gocek E; Novik V; Harrison JS; Danilenko M; Studzinski GP
    Cell Cycle; 2010 Nov; 9(22):4542-51. PubMed ID: 21084834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.
    Pereira F; Barbáchano A; Silva J; Bonilla F; Campbell MJ; Muñoz A; Larriba MJ
    Hum Mol Genet; 2011 Dec; 20(23):4655-65. PubMed ID: 21890490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
    Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
    Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
    BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells.
    Mateen S; Raina K; Agarwal C; Chan D; Agarwal R
    J Pharmacol Exp Ther; 2013 May; 345(2):206-14. PubMed ID: 23461975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
    Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
    Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
    Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
    Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.